⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NMRA News
Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
globenewswire.com
NMRA
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
globenewswire.com
LBRX
NMRA
AMGN
ABT
LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors
globenewswire.com
LBRX
NMRA
AMGN
ABT
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
NMRA
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigation of Neumora Therapeutics, Inc. (NASDAQ:NMRA) and Encourages Long-Term Neumora Investors With Losses to Contact The Firm
accessnewswire.com
NMRA
Catalyst Monitor Report: Q1 2026 Outlook: Regulatory Approvals and Late-Stage Trials Signal Strong Pipeline Momentum Across Key Therapeutic Areas
globenewswire.com
GSK
RGNX
OMER
XENE
NMRA
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
globenewswire.com
NMRA
Neumora Therapeutics Announces Positive Results from NMRA-511 Phase 1b Signal-Seeking Study in Alzheimer’s Disease Agitation
globenewswire.com
NMRA
Neumora Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
NMRA
Neumora Therapeutics to Participate in Upcoming Conferences in November
globenewswire.com
NMRA